Drug recall · February 12, 2014
Namenda XR recall
Why: Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3428-05.
- Lots / codes
Lot 1112467 Exp. 02/15
- Quantity
- 111,384 sample packs
- Company
- Forest Pharmaceuticals Inc, Earth City, MO
- Distribution
- Nationwide and Puerto Rico.
- Initiated
- November 13, 2013 · Voluntary: Firm initiated
- Classified
- February 4, 2014
- Reported
- February 12, 2014
- Ended
- May 7, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Memantine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.